retatrutide clinical trial results 2024 2025 retatrutide weight loss study Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Lilly's triple agonist delivers up
Pay in 4 interest-free payments of $6.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




























